medigraphic.com
ISSN 1561-3070 (Electronic)

2018, Number 4

<< Back Next >>

Rev Cub Oftal 2018; 31 (4)

Acute anterior uveítis associated to hypophosphatemic renal ricketts

Osorio IL, Pérez SRG, Cima LO, Vilches LDC, Hernández FY, Domínguez MA

Language: Spanish
References: 15
Page: 60-66
PDF size: 248.59 Kb.


ABSTRACT

Hereditary hypophosphatemic rickets are a group of diseases characterized by renal loss of phosphates. They appear with disharmonic hypogrowth and bone deformities. The most common form is the X-chromosome-linked hypophosphatemic rickets which is caused by inactivating mutations in PHEX gene. The objective of our work was to describe the ocular alterations and the clinical evolution in a patient with hereditary hypophosphatemic rickets and previous uveitis. Here is the case of a 9 years-old boy diagnosed with hereditary hypophosphatemic rickets, who was seen at the Uveitis Service of “Ramon Pando Ferrer” Cuban Institute of Ophthalmology. He presented with ocular pain and feeling of discomfort to light in his right eye. The ophthalmological exam yielded anterior uveitis with hypopyon in his right eye and crystal depots in the whole corneal thickness and the iris of both eyes. Topical steroids were prescribed to treat the inflammatory process. The findings in the anterior segment of the patients indicated the presence of cystinosis in which the accumulation of crystals is the most typical corneal alteration among the ocular manifestations. Its incidence reaches 90 % in under one year-old children and the first affected organs are the kidneys. The hereditary hypophosphatemic rickets may appear with corneal crystal depots and inflammatory processes in the anterior uvea.


REFERENCES

  1. Velásquez-Jones L, Medeiros-Domingo M. Raquitismos hipofosfatémicos hereditarios. Bol Med Hosp Infant Mex. 2013;70(6):421.

  2. Bonnardeaux A, Bichet DG. Raquitismos hipofosfatémicos hereditarios. Bol Med Hosp Infant Mex. 2013;70(6):42.

  3. Lin X, Zhu Y, Luo J, Huang J. Genetic analysis of three families with X-linked dominant hypophosphatemic rickets. J Pediatr Endocrinol Metab. 2018;26;31(7):789-97.

  4. Barilari C, Exeni R, Santiago A, Álvarez K, Ciancaglini C, Vázquez A. Raquitismo hipofosfatémico hereditario con hipercalcuria. Buenos Aires: Rev Nefrol Dial Traspl. 2015;35(3):1-3. 5. Godina G, Belmont F. Características dentales del raquitismo hipofosfatémico. Reporte de un caso. Rev Odont Mex. 2013;17(2):3.

  5. Acar S, BinEssa HA, Demir K, Al-Rijjal RA, Zou M, Çatli G, et al. Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: novel mutations in PHEX and SLC34A3. PLoS One. 2018;13(3):e0193388.

  6. Aguirre M. Tubulopatías. Santa Cruz de Tenerife: Protoc Diagn Ter Pediatr. 2014;1:135-53.

  7. Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26:1381-8.

  8. Santana-Hernández E, Rodríguez-Font E. Raquitismo hipofosfatémico. Presentación de un caso. Medisur. 2018 [citado 11 de octubre de 2018];16(1). Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/3558

  9. Wöhrle S, Henninger C, Bonny O, Thuery A, Beluch N, Hynes NE, et al. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets. J Bone Miner Res. 2013;28:899-911.

  10. Santos F, Fuente R, Mejia N, Mantecon L, Gil-Peña H, Ordoñez FA. Hypophosphatemia and growth. Pediatr Nephrol. 2013;28:595-603.

  11. Ariceta G, Camacho JA, Fernández-Obispo M. Cistinosis en pacientes adolescentes y adultos: recomendaciones para la atención integral de la cistinosis. Nefrología. 2015;35(3):304-21.

  12. Antignac C, Broissand Ch. Cistinosis, un libro para pacientes y los familiares. Barcelona: Guía cistinosis; 2015 [citado 11 de octubre de 2018]. Disponible en: http://www.grupocistinosis.org/documents/guia_cistinosis_libro.pdf

  13. Kayacan UR, Ünal S. Short-cut diagnostic tool in cystinosis: Bone marrow aspiration. Pediatr Int. 2017;59(11):1178-82.

  14. Liang H, Labbé A, Le Mouhaër J, Plisson C, Baudouin C. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. Invest Ophthalmol Vis Sci. 2017;58(4):2275-83.

  15. Bertholet-Thomas A, Berthiller J, Tasic V, Kassai B, Otukesh H, Greco M, et al. Worldwide view of nephropathic cystinosis: from a survey from 30 countries. BMC Nephrol. 2017;18(1):210.




2020     |     www.medigraphic.com